SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Report Reveals $92 Million Cannabis Sales For Florida in August 

    By

    A new report from Zuanic & Associates has revealed that medical cannabis sales in Florida reached $92 million in August.

    August’s $92 million in sales contributed to a three-month total of $480 million, valuing the industry at $1.44 billion.

    The report shows that the state has an estimated monthly patient expenditure of approximately $145 based on an average of 833,000 registered patients during this period.

    Notably, year-on-year sales from June to August increased by 13%, surpassing the +6% growth seen in the second quarter of 2023 and the +2% growth recorded in both the first quarter of 2023 and the fourth quarter of 2022.

    Writing in the report, Pablo Zuanic of Zuanic & Associates, commented: “Certainly, rec legalization is the next big catalyst for this market. But in the meantime, we note this is already a sizeable medical market at >$1.4Bn, with volume growth north of 30%, and with prices now starting to stabilize (after more than 20% deflation).

    “With stock prices up since the HHS rescheduling news, we would expect more consolidation.”

    With a 2024 ballot initiative set to be voted on that would see the legalisation of adult use of cannabis, the state could generate up to $431.3 million in sales tax if passed.

    This figure was estimated by officials at the state Financial Impact Estimating Conference (FIEC), who also suggested this figure could be higher if an additional excise tax is imposed on retail cannabis sales.

    The FIEC financial impact statement reads: “Based on other states’ experiences, expected retail sales of non-medical marijuana would generate at least $195.6 million annually in state and local sales tax revenues once the retail market is fully operational, although the timing of this occurring is unclear…

    “Because the $195.6 million sales tax estimate represents the lowest suggested level deemed reliable among the six scenarios reviewed (which ranged upward to $431.3 million), it is probable that future changes, if any, to the tax structure would equal or increase the estimated level of new revenue collections. Such changes would require legislative action.”

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free